Cargando…

Myotonic Dystrophy—A Progeroid Disease?

Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness,...

Descripción completa

Detalles Bibliográficos
Autores principales: Meinke, Peter, Hintze, Stefan, Limmer, Sarah, Schoser, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095001/
https://www.ncbi.nlm.nih.gov/pubmed/30140252
http://dx.doi.org/10.3389/fneur.2018.00601
_version_ 1783347903608127488
author Meinke, Peter
Hintze, Stefan
Limmer, Sarah
Schoser, Benedikt
author_facet Meinke, Peter
Hintze, Stefan
Limmer, Sarah
Schoser, Benedikt
author_sort Meinke, Peter
collection PubMed
description Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness, and frontal baldness, but there are also less obvious features like cardiac arrhythmia, diabetes or hypogammaglobulinemia. These aging features suggest the hypothesis that DM could be a segmental progeroid disease. To identify the molecular cause of this characteristic appearance of accelerated aging we compare clinical features of DM to “typical” segmental progeroid disorders caused by mutations in DNA repair or nuclear envelope proteins. Furthermore, we characterize if this premature aging effect is also reflected on the cellular level in DM and investigate overlaps with “classical” progeroid disorders. To investigate the molecular similarities at the cellular level we use primary DM and control cell lines. This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope. Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder.
format Online
Article
Text
id pubmed-6095001
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60950012018-08-23 Myotonic Dystrophy—A Progeroid Disease? Meinke, Peter Hintze, Stefan Limmer, Sarah Schoser, Benedikt Front Neurol Neurology Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the DMPK or CNBP genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness, and frontal baldness, but there are also less obvious features like cardiac arrhythmia, diabetes or hypogammaglobulinemia. These aging features suggest the hypothesis that DM could be a segmental progeroid disease. To identify the molecular cause of this characteristic appearance of accelerated aging we compare clinical features of DM to “typical” segmental progeroid disorders caused by mutations in DNA repair or nuclear envelope proteins. Furthermore, we characterize if this premature aging effect is also reflected on the cellular level in DM and investigate overlaps with “classical” progeroid disorders. To investigate the molecular similarities at the cellular level we use primary DM and control cell lines. This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope. Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder. Frontiers Media S.A. 2018-07-25 /pmc/articles/PMC6095001/ /pubmed/30140252 http://dx.doi.org/10.3389/fneur.2018.00601 Text en Copyright © 2018 Meinke, Hintze, Limmer and Schoser. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Meinke, Peter
Hintze, Stefan
Limmer, Sarah
Schoser, Benedikt
Myotonic Dystrophy—A Progeroid Disease?
title Myotonic Dystrophy—A Progeroid Disease?
title_full Myotonic Dystrophy—A Progeroid Disease?
title_fullStr Myotonic Dystrophy—A Progeroid Disease?
title_full_unstemmed Myotonic Dystrophy—A Progeroid Disease?
title_short Myotonic Dystrophy—A Progeroid Disease?
title_sort myotonic dystrophy—a progeroid disease?
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095001/
https://www.ncbi.nlm.nih.gov/pubmed/30140252
http://dx.doi.org/10.3389/fneur.2018.00601
work_keys_str_mv AT meinkepeter myotonicdystrophyaprogeroiddisease
AT hintzestefan myotonicdystrophyaprogeroiddisease
AT limmersarah myotonicdystrophyaprogeroiddisease
AT schoserbenedikt myotonicdystrophyaprogeroiddisease